Maria Eveslage

German Multicenter Study Investigating¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil et al. · Journal of Nuclear Medicine · 2016 · 832 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

Anja Strangfeld, Maria Eveslage, Matthias Schneider et al. · Annals of the Rheumatic Diseases · 2011 · 362 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival

Kambiz Rahbar, Martin Boegemann, Anna Yordanova et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 160 citations

Medicine, Oncology, Pharmacology +17

Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects

Luisa Klotz, Melanie Eschborn, Maren Lindner et al. · Science Translational Medicine · 2019 · 143 citations · Full text

Life Sciences, Immunology, Neuroscience +16

Nur77 serves as a molecular brake of the metabolic switch during T cell activation to restrict autoimmunity

Marie Liebmann, Stephanie Hucke, Kathrin Koch et al. · Proceedings of the National Academy of Sciences · 2018 · 124 citations · Full text

Life Sciences, Biochemistry, Immunology +17